1
|
Writing Group Members. Mozaffarian D,
Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de
Ferranti S, Després JP, et al: Executive summary: Heart disease and
stroke statistics-2016 update: A report from the American heart
association. Circulation. 133:447–454. 2016.PubMed/NCBI View Article : Google Scholar
|
2
|
Roth JM: Recombinant tissue plasminogen
activator for the treatment of acute ischemic stroke. Proc (Bayl
Univ Med Cent). 24:257–259. 2011.PubMed/NCBI View Article : Google Scholar
|
3
|
Saver JL, Fonarow GC, Smith EE, Reeves MJ,
Grau-Sepulveda MV, Pan W, Olson DM, Hernandez AF, Peterson ED and
Schwamm LH: Time to treatment with intravenous tissue plasminogen
activator and outcome from acute ischemic stroke. JAMA.
309:2480–2488. 2013.PubMed/NCBI View Article : Google Scholar
|
4
|
Mazya MV, Lees KR, Collas D, Rand VM,
Mikulik R, Toni D, Wahlgren N and Ahmed N: IV thrombolysis in very
severe and severe ischemic stroke: Results from the SITS-ISTR
Registry. Neurology. 85:2098–2106. 2015.PubMed/NCBI View Article : Google Scholar
|
5
|
Sung SF, Chen CH, Chen YW, Tseng MC, Shen
HC and Lin HJ: Predicting symptomatic intracerebral hemorrhage
after intravenous thrombolysis: Stroke territory as a potential
pitfall. J Neurol Sci. 335:96–100. 2013.PubMed/NCBI View Article : Google Scholar
|
6
|
Forster A, Gass A, Kern R, Griebe M,
Hennerici MG and Szabo K: Thrombolysis in posterior circulation
stroke: Stroke subtypes and patterns, complications and outcome.
Cerebrovasc Dis. 32:349–353. 2011.PubMed/NCBI View Article : Google Scholar
|
7
|
Dornak T, Král M, Hazlinger M, Herzig R,
Veverka T, Buřval S, Šaňák D, Zapletalová J, Antalíková K and
Kaňovský P: Posterior vs. anterior circulation infarction:
Demography, outcomes, and frequency of hemorrhage after
thrombolysis. Int J Stroke. 10:1224–1228. 2015.PubMed/NCBI View Article : Google Scholar
|
8
|
Breuer L, Huttner HB, Jentsch K, Blinzler
C, Winder K, Engelhorn T and Köhrmann M: Intravenous thrombolysis
in posterior cerebral artery infarctions. Cerebrovasc Dis.
31:448–454. 2011.PubMed/NCBI View Article : Google Scholar
|
9
|
Sarikaya H, Arnold M, Engelter ST, Lyrer
PA, Mattle HP, Georgiadis D, Bonati LH, Fluri F, Fischer U,
Findling O, et al: Outcomes of intravenous thrombolysis in
posterior versus anterior circulation stroke. Stroke. 42:2498–2502.
2011.PubMed/NCBI View Article : Google Scholar
|
10
|
Chinese Society of Neurology, Chinese
Stroke Society. Chinese Guidelines for the Diagnosis and Treatment
of Acute Ischemic Stroke 2018. Chin J Neurol. 51:666–682. 2018.
|
11
|
Keselman B, Gdovinová Z, Jatuzis D, Melo
TPE, Vilionskis A, Cavallo R, Frol S, Jurak L, Koyuncu B, Nunes AP,
et al: Safety and outcomes of intravenous thrombolysis in posterior
versus anterior circulation stroke: Results from the safe
implementation of treatments in stroke registry and meta-analysis.
Stroke. 51:876–882. 2020.PubMed/NCBI View Article : Google Scholar
|
12
|
Tong X, Liao X, Pan Y, Cao Y, Wang C, Liu
L, Zheng H, Zhao X, Wang C, Wang Y, et al: Intravenous thrombolysis
is more safe and effective for posterior circulation stroke: Data
from the thrombolysis implementation and monitor of acute ischemic
stroke in China (TIMS-China). Medicine (Baltimore).
95(e3848)2016.PubMed/NCBI View Article : Google Scholar
|
13
|
Kim JT, Fonarow GC, Smith EE, Reeves MJ,
Navalkele DD, Grotta JC, Grau-Sepulveda MV, Hernandez AF, Peterson
ED, Schwamm LH and Saver JL: Treatment with tissue plasminogen
activator in the golden hour and the shape of the 4.5-hour
time-benefit curve in the National United States get with the
guidelines-stroke population. Circulation. 135:128–139.
2017.PubMed/NCBI View Article : Google Scholar
|
14
|
Liu M, Pan Y, Zhou L and Wang Y:
Predictors of post-thrombolysis symptomatic intracranial hemorrhage
in Chinese patients with acute ischemic stroke. PLoS One.
12(e0184646)2017.PubMed/NCBI View Article : Google Scholar
|
15
|
Guo Y, Yang Y, Zhou M and He L: Risk
factors of haemorrhagic transformation for acute ischaemic stroke
in Chinese patients receiving intravenous recombinant tissue
plasminogen activator: A systematic review and meta-analysis.
Stroke Vasc Neurol. 3:203–208. 2018.PubMed/NCBI View Article : Google Scholar
|
16
|
Lindgren A, Norrving B, Rudling O and
Johansson BB: Comparison of clinical and neuroradiological findings
in first-ever stroke. A population-based study. Stroke.
25:1371–1377. 1994.PubMed/NCBI View Article : Google Scholar
|
17
|
Menon BK, O'Brien B, Bivard A, Spratt NJ,
Demchuk AM, Miteff F, Lu X, Levi C and Parsons MW: Assessment of
leptomeningeal collaterals using dynamic CT angiography in patients
with acute ischemic stroke. J Cereb Blood Flow Metab. 33:365–371.
2013.PubMed/NCBI View Article : Google Scholar
|
18
|
Logallo N, Kvistad CE, Naess H,
Waje-Andreassen U and Thomassen L: Mild stroke: Safety and outcome
in patients receiving thrombolysis. Acta Neurol Scand. Suppl
37-40:2014.PubMed/NCBI View Article : Google Scholar
|
19
|
Willey JZ, Khatri P, Khoury JC, Merino JG,
Ford AL, Rost NS, Gonzales NR, Ali LK, Meyer BC and Broderick JP:
Variability in the use of intravenous thrombolysis for mild stroke:
Experience across the SPOTRIAS network. J Stroke Cerebrovasc Dis.
22:318–322. 2013.PubMed/NCBI View Article : Google Scholar
|
20
|
Sato S, Toyoda K, Uehara T, Toratani N,
Yokota C, Moriwaki H, Naritomi H and Minematsu K: Baseline NIH
Stroke scale score predicting outcome in anterior and posterior
circulation strokes. Neurology. 70 (24 Pt 2):2371–2377.
2008.PubMed/NCBI View Article : Google Scholar
|
21
|
Siegler JE and Martin-Schild S: Early
neurological deterioration (END) after stroke: The END depends on
the definition. Int J Stroke. 6:211–212. 2011.PubMed/NCBI View Article : Google Scholar
|
22
|
Seners P, Turc G, Oppenheim C and Baron
JC: Incidence, causes and predictors of neurological deterioration
occurring within 24 h following acute ischaemic stroke: A
systematic review with pathophysiological implications. J Neurol
Neurosurg Psychiatry. 86:87–94. 2015.PubMed/NCBI View Article : Google Scholar
|
23
|
Saver JL, Gornbein J and Starkman S:
Graphic reanalysis of the two NINDS-tPA trials confirms substantial
treatment benefit. Stroke. 41:2381–2390. 2010.PubMed/NCBI View Article : Google Scholar
|
24
|
Alexandrov AV, Felberg RA, Demchuk AM,
Christou I, Burgin WS, Malkoff M, Wojner AW and Grotta JC:
Deterioration following spontaneous improvement: Sonographic
findings in patients with acutely resolving symptoms of cerebral
ischemia. Stroke. 31:915–919. 2000.PubMed/NCBI View Article : Google Scholar
|
25
|
Grotta JC, Welch KM, Fagan SC, Lu M,
Frankel MR, Brott T, Levine SR and Lyden PD: Clinical deterioration
following improvement in the NINDS rt-PA stroke trial. Stroke.
32:661–668. 2001.PubMed/NCBI View Article : Google Scholar
|
26
|
Simonsen CZ, Schmitz ML, Madsen MH,
Mikkelsen IK, Chandra RV, Leslie-Mazwi T and Andersen G: Early
neurological deterioration after thrombolysis: Clinical and imaging
predictors. Int J Stroke. 11:776–782. 2016.PubMed/NCBI View Article : Google Scholar
|
27
|
Kim JM, Moon J, Ahn SW, Shin HW, Jung KH
and Park KY: The etiologies of early neurological deterioration
after thrombolysis and risk factors of ischemia progression. J
Stroke Cerebrovasc Dis. 25:383–388. 2016.PubMed/NCBI View Article : Google Scholar
|
28
|
Seners P, Turc G, Tisserand M, Legrand L,
Labeyrie MA, Calvet D, Meder JF, Mas JL, Oppenheim C and Baron JC:
Unexplained early neurological deterioration after intravenous
thrombolysis: Incidence, predictors, and associated factors.
Stroke. 45:2004–2009. 2014.PubMed/NCBI View Article : Google Scholar
|
29
|
Frank B, Grotta JC, Alexandrov AV, Bluhmki
E, Lyden P, Meretoja A, Mishra NK, Shuaib A, Wahlgren NG, Weimar C,
et al: Thrombolysis in stroke despite contraindications or
warnings? Stroke. 44:727–733. 2013.PubMed/NCBI View Article : Google Scholar
|
30
|
Yeo LLL, Ho R, Paliwal P, Rathakrishnan R
and Sharma VK: Intravenously administered tissue plasminogen
activator useful in milder strokes? A meta-analysis. J Stroke
Cerebrovasc Dis. 23:2156–2162. 2014.PubMed/NCBI View Article : Google Scholar
|